Generation Bio Co Stock Buy Hold or Sell Recommendation
| GBIO Stock | USD 1.40 0.03 2.19% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Generation Bio Co is 'Strong Buy'. The recommendation algorithm takes into account all of Generation Bio's available fundamental, technical, and predictive indicators you will find on this site.
Check out Generation Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Generation and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Generation |
Execute Generation Bio Buy or Sell Advice
The Generation recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Generation Bio Co. Macroaxis does not own or have any residual interests in Generation Bio Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Generation Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Buy
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Generation Bio Trading Alerts and Improvement Suggestions
| Generation Bio generated a negative expected return over the last 90 days | |
| Generation Bio has high historical volatility and very poor performance | |
| Generation Bio may become a speculative penny stock | |
| Generation Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.9 M. Net Loss for the year was (126.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Generation Bio Co currently holds about 301.17 M in cash with (52.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.07, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 84.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Generation Bio Co. Reports Q3 2024 Financials and Progress - TipRanks |
Generation Bio current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Generation analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Generation analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Generation Bio Returns Distribution Density
The distribution of Generation Bio's historical returns is an attempt to chart the uncertainty of Generation Bio's future price movements. The chart of the probability distribution of Generation Bio daily returns describes the distribution of returns around its average expected value. We use Generation Bio Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Generation Bio returns is essential to provide solid investment advice for Generation Bio.
| Mean Return | -0.83 | Value At Risk | -8.2 | Potential Upside | 9.35 | Standard Deviation | 5.18 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Generation Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Generation Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Generation Bio, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Generation Bio Co back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-09-30 | 1.1 M | State Street Corp | 2024-06-30 | 980.5 K | Ubs Group Ag | 2024-06-30 | 837.8 K | Partner Fund Management Lp | 2024-09-30 | 787.9 K | Renaissance Technologies Corp | 2024-09-30 | 594.3 K | Deutsche Bank Ag | 2024-06-30 | 558 K | D. E. Shaw & Co Lp | 2024-09-30 | 488.1 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 441.1 K | Charles Schwab Investment Management Inc | 2024-09-30 | 423.3 K | T. Rowe Price Associates, Inc. | 2024-06-30 | 9.5 M | Fmr Inc | 2024-09-30 | 5.3 M |
Generation Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 67.9M | (199.7M) | 198.9M | (192.5M) | (9.7M) | (10.2M) | |
| Change In Cash | 7.7M | 47.8M | 315.9M | (282.0M) | (26.6M) | (25.3M) | |
| Free Cash Flow | (60.3M) | (75.7M) | (97.8M) | (111.2M) | (60.1M) | (63.1M) | |
| Depreciation | 1.9M | 3.4M | 4.5M | 5.1M | 5.3M | 3.8M | |
| Other Non Cash Items | (317K) | 249K | 766K | 3.6M | (9.3M) | (8.8M) | |
| Capital Expenditures | 20.0M | 5.5M | 6.0M | 8.8M | 7.4M | 6.8M | |
| Net Income | (61.3M) | (80.5M) | (119.2M) | (136.6M) | (126.6M) | (132.9M) | |
| End Period Cash Flow | 17.2M | 64.9M | 380.8M | 98.9M | 72.2M | 118.0M | |
| Change To Netincome | 3.9M | 8.7M | 18.1M | 30.3M | 34.8M | 36.6M |
Generation Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Generation Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Generation Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Generation stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.25 | |
β | Beta against Dow Jones | 3.47 | |
σ | Overall volatility | 5.19 | |
Ir | Information ratio | -0.19 |
Generation Bio Volatility Alert
Generation Bio Co exhibits very low volatility with skewness of 0.57 and kurtosis of 0.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Generation Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Generation Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Generation Bio Fundamentals Vs Peers
Comparing Generation Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Generation Bio's direct or indirect competition across all of the common fundamentals between Generation Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Generation Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Generation Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Generation Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Generation Bio to competition |
| Fundamentals | Generation Bio | Peer Average |
| Return On Equity | -0.86 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Operating Margin | (2.21) % | (5.51) % |
| Current Valuation | 515.17 K | 16.62 B |
| Shares Outstanding | 66.79 M | 571.82 M |
| Shares Owned By Insiders | 14.51 % | 10.09 % |
| Shares Owned By Institutions | 83.88 % | 39.21 % |
| Number Of Shares Shorted | 1.66 M | 4.71 M |
| Price To Book | 0.88 X | 9.51 X |
| Price To Sales | 5.03 X | 11.42 X |
| Revenue | 5.9 M | 9.43 B |
| EBITDA | (133.3 M) | 3.9 B |
| Net Income | (126.61 M) | 570.98 M |
| Cash And Equivalents | 301.17 M | 2.7 B |
| Cash Per Share | 5.07 X | 5.01 X |
| Total Debt | 97.89 M | 5.32 B |
| Debt To Equity | 0.27 % | 48.70 % |
| Current Ratio | 17.93 X | 2.16 X |
| Book Value Per Share | 1.56 X | 1.93 K |
| Cash Flow From Operations | (52.74 M) | 971.22 M |
| Short Ratio | 17.16 X | 4.00 X |
| Earnings Per Share | (2.19) X | 3.12 X |
| Target Price | 7.5 | |
| Number Of Employees | 174 | 18.84 K |
| Beta | 2.82 | -0.15 |
| Market Capitalization | 93.51 M | 19.03 B |
| Total Asset | 374.76 M | 29.47 B |
| Retained Earnings | (571.38 M) | 9.33 B |
| Working Capital | 232.7 M | 1.48 B |
| Net Asset | 374.76 M |
Note: Disposition of 983 shares by Howze Yalonda of Generation Bio subject to Rule 16b-3 [view details]
Generation Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Generation . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Generation Bio Buy or Sell Advice
When is the right time to buy or sell Generation Bio Co? Buying financial instruments such as Generation Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Generation Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Oil And Gas Thematic Idea Now
Oil And Gas
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Generation Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.28 | Quarterly Revenue Growth 2.52 | Return On Assets (0.19) | Return On Equity (0.86) |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.